Lv3
310 积分 2025-04-11 加入
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
14天前
已完结
Impact of EGFR-TKIs combined with PD-L1 antibody on the lung tissue of EGFR-driven tumor-bearing mice
24天前
已完结
The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity
24天前
已完结
The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity
24天前
已完结
Abstract 4835: LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions
26天前
已关闭
Fibroblast growth factor therapies in biliary tract cancers: current and future state
26天前
已完结
Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer
1个月前
已完结
Next-generation isoform-selective fibroblast growth factor receptor inhibitors
1个月前
已完结
Discovery of Potent FGFR2/3 Inhibitors to Overcome Mutation Resistance and Treat Achondroplasia
1个月前
已完结
Low–dose infigratinib increases bone growth and corrects growth plate abnormalities in an achondroplasia mouse model
1个月前
已完结
皖公网安备34019202002308
